Cardio Diagnostics Holdings, Inc. (CDIO)
NASDAQ: CDIO · Real-Time Price · USD
1.755
+0.145 (9.01%)
May 26, 2026, 2:26 PM EDT - Market open

CDIO Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-6.65-6.5-8.38-8.38-4.66-0.62
Depreciation & Amortization
0.370.40.280.110.020.02
Stock-Based Compensation
0.10.112.591.28-0.06
Other Adjustments
---1.10.11-0
Change in Receivables
0.010.01-0.01-00-0
Changes in Other Operating Activities
0.290.250.540.21-0.56-0.04
Operating Cash Flow
-5.89-5.73-4.99-5.67-5.09-0.59
Capital Expenditures
-0.18-0.19-0.21-0.58--
Purchases of Intangible Assets
-0.17-0.23-0.19-0.2-0.08-0.11
Other Investing Activities
----0.02-0.29-0.25
Investing Cash Flow
-0.44-0.42-0.4-0.79-0.37-0.36
Long-Term Debt Issued
---4.5--
Net Long-Term Debt Issued (Repaid)
---4.5--
Issuance of Common Stock
4.073.812.390.3911.991.23
Net Common Stock Issued (Repurchased)
4.073.812.390.3911.991.23
Other Financing Activities
-0.36-0.37-0.45-1.26-2.92-
Financing Cash Flow
3.713.4311.943.639.061.23
Net Cash Flow
-2.61-2.726.54-2.833.60.28
Free Cash Flow
-6.07-5.91-5.21-6.25-5.09-0.59
FCF Margin
-36657.00%-39893.10%-14926.50%-36612.00%-535891.00%-64960.20%
Free Cash Flow Per Share
-2.98-3.38-5.81-14.78-49.46-15.09
Levered Free Cash Flow
-6.18-6.03-7.79-4.13-5.2-0.64
Unlevered Free Cash Flow
-6.17-6.02-7.77-7.49-5.09-0.64
Updated May 15, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q